Measurement of lithium pharmacokinetics with the Medimate Multireader® in cluster headache patients
- Conditions
- Cluster headacheHorton syndrome10019231
- Registration Number
- NL-OMON34105
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 22
Inclusion Criteria
Diagnosed with cluster headache according to The International Classification of Headache Disorders, 2nd Edition. The patients should have a stable lithium intake for at least 3 weeks.
Exclusion Criteria
Patients with significant renal disease which may interfere with the study, or patients with other significant neurological or disabling diseases than CH, are excluded from this study.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To determine whether there is a correlation between the frequency of cluster<br /><br>headache attacks and the absminLi.</p><br>
- Secondary Outcome Measures
Name Time Method <p>We will describe the relation between the t1/2 and 12h-Li and the frequency of<br /><br>attacks. Furthermore, we will compare the results of the Liattack with the<br /><br>Licontrol measurements. Finally, we will evaluate the use of additional<br /><br>medication and the kidney function. </p><br>